Phase II Study of Obatoclax Mesylate (GX15-070), a Small-Molecule BCL-2 Family Antagonist, for Patients With Myelofibrosis - Clinical Lymphoma, Myeloma and Leukemia
IJMS | Free Full-Text | Obatoclax, a Pan-BCL-2 Inhibitor, Targets Cyclin D1 for Degradation to Induce Antiproliferation in Human Colorectal Carcinoma Cells | HTML
Obatoclax has single agent activity against cholangiocarcinoma which is... | Download Scientific Diagram
Obatoclax mesylate (GX15-070) | C21H23N3O4S - PubChem
Obatoclax Mesylate, a Pan–Bcl-2 Inhibitor, in Combination with Docetaxel in a Phase 1/2 Trial in Relapsed Non–Small-Cell Lung Cancer - Journal of Thoracic Oncology
Obatoclax - an overview | ScienceDirect Topics
The pan-Bcl-2 inhibitor obatoclax promotes differentiation and apoptosis of acute myeloid leukemia cells | SpringerLink
803712-79-0 Obatoclax mesylate AKSci V2454
Small molecule obatoclax (GX15-070) antagonizes MCL-1 and overcomes MCL-1-mediated resistance to apoptosis | PNAS
Small molecule obatoclax (GX15-070) antagonizes MCL-1 and overcomes MCL-1-mediated resistance to apoptosis | PNAS
Obatoclax Mesylate (GX15-070) | ≥99%(HPLC) | Selleck | Bcl-2 antagonist
Randomized phase II study of carboplatin and etoposide with or without obatoclax mesylate in extensive-stage small cell lung cancer - Lung Cancer
Dual mTORC1/2 inhibition compromises cell defenses against exogenous stress potentiating Obatoclax-induced cytotoxicity in atypical teratoid/rhabdoid tumors | Cell Death & Disease
Obatoclax - Wikipedia
Obatoclax Mesylate (GX15-070 Mesylate) | Bcl-2 Family Inhibitor | MedChemExpress
A Multicenter Phase I/II Study of Obatoclax Mesylate Administered as a 3- or 24-Hour Infusion in Older Patients with Previously Untreated Acute Myeloid Leukemia | PLOS ONE
Drugs and Clinical Approaches Targeting the Antiapoptotic Protein: A Review
OBATOCLAX
Obatoclax - an overview | ScienceDirect Topics
Pan-Bcl-2 inhibitor Obatoclax is a potent late stage autophagy inhibitor in colorectal cancer cells independent of canonical autophagy signaling | BMC Cancer | Full Text
Obatoclax induced autophagy leads to cell death. (A) A time course... | Download Scientific Diagram
Obatoclax Mesylate (GX15-070 Mesylate) | Bcl-2 Family Inhibitor | MedChemExpress
Lapatinib and obatoclax treatment induces an ER stress response that... | Download Scientific Diagram
Small molecule obatoclax (GX15-070) antagonizes MCL-1 and overcomes MCL-1-mediated resistance to apoptosis | PNAS
Obatoclax - LKT Labs
Pan-Bcl-2 inhibitor Obatoclax is a potent late stage autophagy inhibitor in colorectal cancer cells independent of canonical autophagy signaling | BMC Cancer | Full Text
Phase I study of obatoclax mesylate (GX15-070), a small molecule pan–Bcl-2 family antagonist, in patients with advanced chronic lymphocytic leukemia - ScienceDirect
